Literature DB >> 32812143

Reliability, construct validity, and measurement invariance of the PROMIS Physical Function 8b-Adult Short Form v2.0.

Du Feng1, Fimbel Laurel2, Dorothy Castille3, Alma Knows His Gun McCormick4, Suzanne Held2.   

Abstract

PURPOSE: The National Institutes of Health established the Patient-Reported Outcomes Measurement Information System (PROMIS) to assess health across various chronic illnesses. The standardized PROMIS measures have been used to assess symptoms in studies that included Native American participants, although the psychometric properties of these measures have not been assessed among a solely Native American population. This study aimed to assess the reliability, construct validity, and measurement invariance of a widely used PROMIS Physical Function survey among Native Americans residing on or near the Apsáalooke (Crow) Reservation who were living with chronic illnesses.
METHODS: Participants aged 24 to 82 years and living with at least one chronic illness were recruited for a community-based participatory research project. Baseline data were used for the current study (N = 210). The 8-item PROMIS Physical Function 8b-Adult Short Form v2.0 was used to assess the function of upper and lower extremities, central core regions, and the ability to complete daily activities on a 5-point Likert scale.
RESULTS: Results indicated that the above PROMIS survey had high internal consistency (Cronbach's α = 0.95) and split-half (r = 0.92, p < 0.001) reliabilities. Confirmatory factor analyses supported construct validity among females of the above population and when the two sex groups were combined. Results also indicated that corresponding thresholds and factor loadings were invariant across male and female groups.
CONCLUSIONS: The above PROMIS measure had good psychometric properties in females and when the two sex groups were combined among Native American adults living on or near the Apsáalooke reservation with chronic illnesses. Thresholds and factor loadings appeared to be invariant by sex. Future studies with a larger sample size among males and more studies on the psychometric properties of other PROMIS measures among Native American populations are needed.

Entities:  

Keywords:  Chronic Illness; Native American; PROMIS measure; Physical function; Psychometric properties

Mesh:

Year:  2020        PMID: 32812143      PMCID: PMC7686045          DOI: 10.1007/s11136-020-02603-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

1.  A breakdown of reliability coefficients by test type and reliability method, and the clinical implications of low reliability.

Authors:  Richard A Charter
Journal:  J Gen Psychol       Date:  2003-07

2.  Community-building versus career-building research: the challenges, risks, and responsibilities of conducting research with Aboriginal and Native American communities.

Authors:  Terry Leigh Mitchell; Emerance Baker
Journal:  J Cancer Educ       Date:  2005       Impact factor: 2.037

3.  Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  M Rose; J B Bjorner; J Becker; J F Fries; J E Ware
Journal:  J Clin Epidemiol       Date:  2008-01       Impact factor: 6.437

4.  Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.

Authors:  Roxanne E Jensen; Arnold L Potosky; Bryce B Reeve; Elizabeth Hahn; David Cella; James Fries; Ashley Wilder Smith; Theresa H M Keegan; Xiao-Cheng Wu; Lisa Paddock; Carol M Moinpour
Journal:  Qual Life Res       Date:  2015-05-03       Impact factor: 4.147

5.  A lower extremity physical function computerized adaptive testing instrument for orthopaedic patients.

Authors:  Man Hung; Daniel O Clegg; Tom Greene; Charlene Weir; Charles L Saltzman
Journal:  Foot Ankle Int       Date:  2012-04       Impact factor: 2.827

Review 6.  The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research.

Authors:  Maria B Boyce; John P Browne; Joanne Greenhalgh
Journal:  BMJ Qual Saf       Date:  2014-02-06       Impact factor: 7.035

7.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Authors:  David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays
Journal:  J Clin Epidemiol       Date:  2010-08-04       Impact factor: 6.437

8.  PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.

Authors:  J S Bajaj; L R Thacker; J B Wade; A J Sanyal; D M Heuman; R K Sterling; D P Gibson; R T Stravitz; P Puri; M Fuchs; V Luketic; N Noble; M White; D Bell; D A Revicki
Journal:  Aliment Pharmacol Ther       Date:  2011-09-19       Impact factor: 8.171

9.  Patient reported outcome measures could help transform healthcare.

Authors:  Nick Black
Journal:  BMJ       Date:  2013-01-28

10.  Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis.

Authors:  Susan J Bartlett; Ana-Maria Orbai; Trisha Duncan; Elaine DeLeon; Victoria Ruffing; Katherine Clegg-Smith; Clifton O Bingham
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

View more
  1 in total

1.  Can the Knee Outcome and Osteoarthritis Score (KOOS) Function Subscale Be Linked to the PROMIS Physical Function to Crosswalk Equivalent Scores?

Authors:  Marilyn Heng; Xiaodan Tang; Benjamin D Schalet; Austin K Collins; Antonia F Chen; Christopher M Melnic; Todd M O'Brien; Rachel C Sisodia; Patricia D Franklin; David Cella
Journal:  Clin Orthop Relat Res       Date:  2021-12-01       Impact factor: 4.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.